Galdu-irabazien kontua
OCULAR THERAPEUTIX, INC
OCUL
Errendimenduaren laburpena
Egin klik taulako edozein lerrotan grafikoan gehitzeko
milioika USDtan
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Diru-sarrerak
|
51.95 | 63.72 | 58.44 | 51.49 | 43.52 | 17.40 | 4.23 | 1.99 | 1.92 | 1.89 | 1.75 | 0.77 |
|
Diru-sarreren kostua
|
6.57 | 5.63 | 5.28 | 4.54 | 4.41 | 2.08 | 2.33 | 0.47 | - | - | - | - |
|
Irabazi gordina
|
45.38 | 58.10 | 53.16 | 46.95 | 39.12 | 15.32 | 1.90 | 1.53 | 1.92 | 1.89 | 1.75 | 0.77 |
|
Ustiapen-gastuak
|
261.47 | 188.29 | 95.00 | 85.69 | 81.96 | 51.55 | 63.21 | 55.70 | 46.39 | 38.07 | 39.95 | 27.87 |
|
Ikerketa eta garapena
|
197.10 | 127.64 | 61.06 | 53.46 | 50.08 | 28.69 | 41.09 | 36.92 | 30.88 | 27.07 | 26.61 | 18.88 |
|
Salmentak, orokorrak eta administratiboak
|
64.38 | 60.65 | 40.55 | 39.92 | 35.19 | 26.61 | 24.49 | 18.79 | 17.00 | 11.00 | 9.17 | 6.91 |
|
Beste ustiapen-gastu batzuk
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Ustiapen-irabaziak
|
-216.10 | -130.19 | -41.83 | -38.73 | -42.85 | -36.23 | -61.31 | -54.18 | -44.47 | -36.18 | -38.20 | -27.09 |
|
Ez-ustiapeneko diru-sarrerak
|
4.08 | -21.73 | 1.65 | 7.62 | 71.48 | -92.79 | -0.57 | -0.86 | -1.46 | -1.38 | -1.55 | -1.55 |
|
Interesen diru-sarrerak
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Interesen gastuak
|
- | 0.89 | 11.34 | 7.02 | 6.67 | 6.77 | 6.10 | 1.74 | 1.89 | 1.68 | 1.72 | 1.12 |
|
Beste ez-ustiapeneko diru-sarrerak/gastuak
|
- | - | 0.00 | 0.00 | 0.00 | - | -0.01 | - | 0.01 | 0.00 | 0.01 | -0.44 |
|
Zerga aurreko irabazia
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Zerga-gastua
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Partaidetza ez-kontrolatzailea
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
Irabazi garbia
|
-265.94 | -193.51 | -80.74 | -71.04 | -6.55 | -155.64 | -86.37 | -59.98 | -63.39 | -44.70 | -39.75 | -28.65 |
Informazio osagarria
Akzioko datuak, eratorritakoak eta bestelakoak — ez dira galdu-irabazien kontuaren parte
milioika USDtan, bestela adierazi ezean
| Neurria | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Amortizazioa eta balio-galera
|
- | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-211.77 | -126.41 | -38.85 | -36.62 | -40.43 | -33.46 | -58.78 | -51.89 | -42.84 | -35.30 | -37.44 | -26.55 |
|
Akzioko irabazia (oinarrizkoa)
|
-1.42 | -1.22 | -1.01 | -0.92 | -0.09 | - | - | - | - | - | - | - |
|
EPS diluitua
|
-1.42 | -1.22 | -1.02 | -0.97 | -0.98 | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatua
|
187.24 | 158.27 | 79.83 | 76.88 | 76.39 | - | - | - | - | - | - | - |
|
Akzioen batez besteko haztatu diluitua
|
187.24 | 158.27 | 85.60 | 82.64 | 82.16 | - | - | - | - | - | - | - |
|
Irabazi globala
|
- | - | - | - | - | - | -86.37 | -59.98 | -63.38 | -44.64 | -39.82 | - |